Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPRED1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
mRNA | GABPB2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | SESTD1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | PITPNM2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | BEST3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | TTL | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
mRNA | SERPIND1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | LILRA2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | TAF7L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | STARD6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |